Grazax(R), Grass Pollen Allergen Tablet, Launched For Use In Children
ALK-Abelló Ltd announced today that Grazax®, grass-pollen allergen tablet, is now available for use in children and adolescents aged 5 to 17. Grazax is the only non-injection immunotherapy licensed to treat children suffering from severe grass pollen induced seasonal allergic rhinitis and conjunctivitis or severe hay fever1. In addition, it is the first immunotherapy tablet to address the underlying cause of grass pollen allergy2,3.
(more...)
(more...)